Impact of low‐volume blood withdrawal on hematological biomarkers for the athlete biological passport
Drug Testing and Analysis · 2024
DOI: 10.1002/dta.3528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2024. Verfasst von B Krumm und 3 weiteren Autor:innen. Beteiligte Einrichtung: REDs, Research & Expertise in anti-Doping sciences, Institute of Sport Sciences, University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Doping in Sports. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This study investigated the impact of low‐volume blood withdrawal on the hematological biomarkers currently considered for anti‐doping purposes. After baseline measurement (D − 7), a 140 mL blood withdrawal was completed (D + 0) on 12 healthy volunteers, followed by weekly monitoring for 21 days (D + 7 – 21). Each visit consisted of a full blood count (Sysmex XN‐1000) and duplicate blood volume measurements by CO‐rebreathing. A significant decrease in total hemoglobin mass (Hbmass) (−2.3%, p = 0.007) and red blood cell volume (RBCV) (−2.8%, p = 0.028) was reported at D + 7. Despite no atypical passport finding (ATPF) when considering the athlete biological passport adaptive longitudinal model, hemoglobin concentration ([Hb]) increased significantly at D + 21 (+3.8%, p = 0.031). Besides, ferritin (FERR) was significantly downregulated at all points following blood withdrawal, with the largest decrease occurring at D + 7 (−26.6%, p < 0.001). Regardless of the presumable effect of blood reinfusion on ABP biomarkers, these results illustrate the challenge of monitoring hematological variables for the detection of low‐volume blood withdrawal. Finally, this study outlines the sensitivity of FERR to altered erythropoiesis to support the implementation of iron markers as complementary variables for the longitudinal monitoring of blood doping, despite the potential influence of confounding factors (e.g., iron supplementations).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- REDs, Research & Expertise in anti-Doping sciences, Institute of Sport Sciences, University of Lausanne, Lausanne, Switzerland.
Zitieren
APA
Krumm, B., Saugy, J. J., Botrè, F., & Faiss, R. (2024). Impact of low‐volume blood withdrawal on hematological biomarkers for the athlete biological passport. Drug Testing and Analysis. https://doi.org/10.1002/dta.3528
Vancouver
Krumm B, Saugy JJ, Botrè F, Faiss R. Impact of low‐volume blood withdrawal on hematological biomarkers for the athlete biological passport. Drug Testing and Analysis. 2024. doi:10.1002/dta.3528
BibTeX
@article{Krumm2024,
author = {Krumm, B and Saugy, J J and Botrè, F and Faiss, R},
title = {Impact of low‐volume blood withdrawal on hematological biomarkers for the athlete biological passport},
journal = {Drug Testing and Analysis},
year = {2024},
doi = {10.1002/dta.3528}
}
EUVIMED